Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Barry Uretsky

Concepts (785)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
97
2024
299
22.910
Why?
Coronary Occlusion
58
2023
78
13.230
Why?
Coronary Artery Disease
42
2024
273
13.100
Why?
Fractional Flow Reserve, Myocardial
39
2023
126
11.840
Why?
Angioplasty, Balloon, Coronary
55
2020
137
11.330
Why?
Coronary Angiography
115
2023
353
9.060
Why?
Stents
54
2023
346
8.970
Why?
Coronary Vessels
37
2024
158
8.050
Why?
Coronary Stenosis
22
2021
99
6.420
Why?
Myocardial Infarction
52
2024
392
5.500
Why?
Drug-Eluting Stents
22
2023
92
5.090
Why?
Treatment Outcome
129
2024
5174
4.810
Why?
Cardiac Catheterization
33
2023
214
4.230
Why?
Heart Failure
58
2021
505
3.380
Why?
Coronary Artery Bypass
19
2022
122
3.160
Why?
Humans
333
2024
49877
3.050
Why?
Acute Coronary Syndrome
8
2022
78
2.950
Why?
Chronic Disease
55
2023
565
2.500
Why?
Tomography, Optical Coherence
8
2018
104
2.370
Why?
Coronary Disease
27
2015
152
2.310
Why?
Saphenous Vein
14
2021
63
2.280
Why?
Risk Factors
78
2023
3608
2.240
Why?
Graft Occlusion, Vascular
13
2021
74
2.170
Why?
Platelet Aggregation Inhibitors
12
2014
174
2.150
Why?
Coronary Thrombosis
9
2020
25
2.110
Why?
Male
193
2024
25427
2.070
Why?
Myocardial Ischemia
13
2020
117
1.860
Why?
Predictive Value of Tests
28
2023
907
1.840
Why?
Registries
33
2023
522
1.840
Why?
Cardiology
14
2019
91
1.840
Why?
Aged
105
2023
9450
1.830
Why?
Middle Aged
147
2024
12289
1.820
Why?
Coronary Restenosis
8
2021
31
1.730
Why?
Thrombosis
11
2018
249
1.730
Why?
Myocardium
20
2013
443
1.670
Why?
Time Factors
53
2023
2890
1.630
Why?
Heptanoic Acids
15
2008
34
1.580
Why?
Pyrroles
15
2008
68
1.540
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
13
2022
137
1.460
Why?
Risk Assessment
30
2023
1253
1.460
Why?
Female
146
2024
26555
1.400
Why?
Heart Injuries
3
2019
15
1.400
Why?
Cardiac Tamponade
4
2024
27
1.310
Why?
Ventricular Function, Left
16
2023
158
1.310
Why?
Cardiotonic Agents
23
2019
82
1.310
Why?
Myocardial Reperfusion Injury
10
2011
48
1.260
Why?
Hemodynamics
41
2018
263
1.240
Why?
Postoperative Complications
18
2019
1018
1.200
Why?
Collateral Circulation
10
2020
39
1.170
Why?
Heart Transplantation
31
2009
350
1.160
Why?
Vasodilator Agents
8
2016
98
1.130
Why?
Coronary Circulation
11
2024
59
1.080
Why?
Societies, Medical
10
2019
177
1.070
Why?
Heart-Assist Devices
4
2020
151
1.070
Why?
Ventricular Dysfunction, Left
9
2018
101
1.020
Why?
Contrast Media
9
2018
186
1.000
Why?
Prosthesis Design
11
2021
240
0.980
Why?
Cardiac Catheters
4
2020
12
0.980
Why?
Thrombolytic Therapy
2
2020
110
0.970
Why?
Death, Sudden, Cardiac
6
2008
57
0.930
Why?
Pericarditis
2
2022
21
0.930
Why?
Algorithms
6
2021
613
0.910
Why?
Adenosine
7
2018
70
0.900
Why?
Balloon Occlusion
1
2024
17
0.900
Why?
Pericardial Effusion
1
2024
39
0.880
Why?
Hemorrhage
4
2019
194
0.880
Why?
Digitalis
2
2021
5
0.870
Why?
Cardiovascular Agents
5
2009
54
0.860
Why?
Occupational Health
1
2023
66
0.830
Why?
Aneurysm, False
5
2020
43
0.830
Why?
Pericarditis, Constrictive
1
2022
2
0.830
Why?
Retrospective Studies
32
2020
6118
0.810
Why?
Digoxin
12
2021
30
0.800
Why?
Aorta
4
2019
162
0.800
Why?
Hypotension, Controlled
1
2021
3
0.780
Why?
Radiography, Interventional
7
2018
57
0.780
Why?
Anemia
1
2022
66
0.770
Why?
Angina, Unstable
8
2016
22
0.750
Why?
Thrombocytopenia
1
2022
79
0.750
Why?
Mammary Arteries
3
2017
8
0.740
Why?
Follow-Up Studies
27
2019
2176
0.740
Why?
Absorbable Implants
2
2022
16
0.740
Why?
Prognosis
19
2023
1957
0.730
Why?
Inferior Wall Myocardial Infarction
1
2020
1
0.720
Why?
Thiazolidinediones
6
2008
82
0.710
Why?
Time-to-Treatment
2
2020
70
0.700
Why?
Shock, Cardiogenic
1
2020
25
0.690
Why?
Cardiovascular Diseases
11
2015
447
0.680
Why?
Stroke Volume
18
2023
130
0.670
Why?
Diabetic Angiopathies
2
2013
17
0.670
Why?
Prospective Studies
28
2023
2342
0.670
Why?
Heart Ventricles
8
2012
252
0.670
Why?
Enbucrilate
1
2019
6
0.670
Why?
Tissue Adhesives
1
2019
13
0.660
Why?
Arterial Pressure
1
2019
44
0.660
Why?
Practice Guidelines as Topic
3
2020
456
0.660
Why?
Hyperemia
3
2016
18
0.660
Why?
Pericardium
4
2022
28
0.660
Why?
Operative Time
3
2019
71
0.640
Why?
Guideline Adherence
1
2020
133
0.640
Why?
Adrenergic beta-Antagonists
5
2008
106
0.630
Why?
Aspirin
5
2022
111
0.620
Why?
Hematoma
2
2013
64
0.610
Why?
Troponin T
3
2011
13
0.610
Why?
Electrocardiography
16
2022
259
0.610
Why?
Severity of Illness Index
19
2019
953
0.600
Why?
Heart Septum
3
2010
24
0.600
Why?
Hydrostatic Pressure
1
2017
7
0.590
Why?
Angioplasty, Balloon
4
2022
66
0.580
Why?
Perioperative Care
5
2015
42
0.570
Why?
Angiotensin-Converting Enzyme Inhibitors
10
2011
74
0.570
Why?
Creatine Kinase, MB Form
3
2013
6
0.570
Why?
Surgical Procedures, Operative
4
2015
66
0.550
Why?
Foramen Ovale, Patent
2
2014
27
0.550
Why?
Defibrillators, Implantable
5
2007
63
0.550
Why?
United States
28
2022
4873
0.550
Why?
Purinergic P2Y Receptor Antagonists
2
2014
29
0.540
Why?
Randomized Controlled Trials as Topic
13
2021
550
0.530
Why?
Propranolol
3
2008
78
0.530
Why?
Kidney Failure, Chronic
4
2004
199
0.530
Why?
Heart
10
2006
336
0.520
Why?
Veterans
1
2022
564
0.510
Why?
Tissue Donors
2
2013
111
0.510
Why?
Alloys
2
2020
9
0.500
Why?
Incidence
16
2018
989
0.500
Why?
Heart Rupture, Post-Infarction
3
2005
4
0.490
Why?
Aortic Valve
3
2022
109
0.490
Why?
Physician-Patient Relations
2
2015
143
0.480
Why?
Fibrinolytic Agents
3
2014
125
0.480
Why?
Vascular System Injuries
1
2015
37
0.480
Why?
Tomography, X-Ray Computed
5
2013
1150
0.480
Why?
Wounds, Penetrating
1
2015
39
0.480
Why?
Ultrasonography, Interventional
7
2013
137
0.460
Why?
Purines
2
2014
38
0.460
Why?
Adenosine A2 Receptor Agonists
1
2014
5
0.460
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
3
2009
32
0.460
Why?
Lisinopril
7
2003
13
0.460
Why?
Anterior Wall Myocardial Infarction
2
2012
7
0.450
Why?
Computer-Assisted Instruction
1
2014
30
0.450
Why?
Clinical Trials as Topic
9
2012
466
0.450
Why?
Metals
2
2011
35
0.450
Why?
Cyclooxygenase 2
8
2008
43
0.440
Why?
Piperazines
2
2012
118
0.440
Why?
Pyrazoles
2
2014
110
0.440
Why?
Blood Vessel Prosthesis Implantation
4
2009
121
0.440
Why?
Anticholesteremic Agents
3
2008
28
0.440
Why?
Mentors
1
2014
55
0.430
Why?
Coronary Vessel Anomalies
3
2017
38
0.430
Why?
Arteries
1
2013
91
0.430
Why?
Atrial Function, Left
1
2013
4
0.430
Why?
Endarterectomy, Carotid
2
2011
62
0.430
Why?
Lipoxins
3
2008
3
0.430
Why?
Cardiac Surgical Procedures
3
2014
303
0.420
Why?
Imidazoles
9
1990
128
0.420
Why?
Drug Administration Schedule
7
2014
368
0.420
Why?
Coronary Aneurysm
2
2007
18
0.420
Why?
Pressure
4
2017
105
0.410
Why?
Drug Eruptions
1
2012
13
0.410
Why?
Rats, Sprague-Dawley
14
2008
1578
0.410
Why?
Physicians
2
2015
229
0.410
Why?
Thiophenes
1
2012
36
0.400
Why?
Rats
19
2011
3273
0.400
Why?
Stroke
3
2013
478
0.400
Why?
Double-Blind Method
14
2020
679
0.390
Why?
Embolism
2
2013
20
0.390
Why?
Cyclooxygenase Inhibitors
5
2007
37
0.390
Why?
Quality Assurance, Health Care
4
2012
149
0.390
Why?
Diverticulum
1
2011
21
0.380
Why?
Internet
1
2014
261
0.380
Why?
Troponin I
1
2011
18
0.370
Why?
Transurethral Resection of Prostate
1
2011
10
0.370
Why?
Carotid Arteries
1
2011
82
0.370
Why?
Intraoperative Complications
4
2020
113
0.370
Why?
Myocytes, Cardiac
5
2011
122
0.370
Why?
Receptors, Adrenergic, beta-2
2
2009
16
0.370
Why?
Embolic Protection Devices
1
2010
6
0.360
Why?
Paclitaxel
1
2011
83
0.360
Why?
Receptors, Opioid, delta
2
2009
25
0.360
Why?
Clinical Competence
4
2013
395
0.360
Why?
Pericardiectomy
2
2024
6
0.350
Why?
Mitral Valve
1
2010
50
0.350
Why?
Endocarditis
1
2010
31
0.350
Why?
Adult
49
2019
13344
0.350
Why?
Kaplan-Meier Estimate
6
2017
463
0.340
Why?
Calcinosis
4
2023
52
0.340
Why?
Anticoagulants
6
2024
253
0.330
Why?
Cardiac Output, Low
5
2006
11
0.330
Why?
Suction
2
2008
23
0.330
Why?
Sirolimus
2
2009
62
0.330
Why?
Echocardiography, Transesophageal
2
2006
60
0.320
Why?
Hypoglycemic Agents
3
2006
169
0.320
Why?
Heart Valve Prosthesis
3
2022
78
0.320
Why?
Carotid Artery, Common
2
2006
44
0.310
Why?
Myocardial Bridging
1
2008
2
0.310
Why?
Tissue Plasminogen Activator
1
2009
110
0.310
Why?
Heart Failure, Systolic
1
2008
7
0.310
Why?
Aortic Valve Stenosis
3
2022
60
0.310
Why?
Peptides
2
2008
220
0.310
Why?
Azetidines
1
2008
6
0.300
Why?
Creatinine
3
2004
140
0.300
Why?
Consensus
2
2007
155
0.300
Why?
Patient Selection
7
2012
254
0.300
Why?
Exercise Test
10
2002
129
0.290
Why?
Survival Analysis
13
2010
670
0.290
Why?
Heart Septal Defects, Atrial
2
2013
44
0.290
Why?
Animals
28
2022
13098
0.290
Why?
Telemedicine
1
2014
465
0.290
Why?
Drug Therapy, Combination
10
2008
378
0.290
Why?
Proportional Hazards Models
10
2017
406
0.280
Why?
Vascular Patency
5
2020
83
0.280
Why?
Mitral Valve Insufficiency
3
2007
45
0.280
Why?
Aortic Valve Insufficiency
2
2016
20
0.280
Why?
Laboratories, Hospital
1
2006
6
0.280
Why?
Terminology as Topic
3
2013
63
0.270
Why?
Pacemaker, Artificial
1
2007
32
0.270
Why?
Echocardiography, Three-Dimensional
1
2006
12
0.270
Why?
Chi-Square Distribution
3
2017
276
0.270
Why?
Bacteremia
1
2007
90
0.260
Why?
Inpatients
2
2018
193
0.250
Why?
Gadolinium DTPA
1
2005
25
0.250
Why?
Chest Pain
3
2006
55
0.250
Why?
Lipopolysaccharides
1
2006
195
0.250
Why?
Nitric Oxide Synthase Type III
6
2008
78
0.250
Why?
Carotid Artery Diseases
1
2005
32
0.250
Why?
Neovascularization, Physiologic
2
2005
68
0.250
Why?
Angina, Stable
2
2016
7
0.250
Why?
Europe
8
2019
75
0.250
Why?
Prostaglandins
1
2005
20
0.240
Why?
Risk
8
2011
314
0.240
Why?
Arginine Vasopressin
6
2005
13
0.240
Why?
Calcium
1
2007
401
0.240
Why?
Atrial Fibrillation
4
2021
182
0.240
Why?
Pain Management
3
2015
164
0.240
Why?
Program Evaluation
1
2006
347
0.240
Why?
Dobutamine
6
1999
22
0.240
Why?
Renal Insufficiency
1
2005
107
0.240
Why?
Chemokine CCL2
1
2004
67
0.240
Why?
Dose-Response Relationship, Drug
12
2017
1354
0.240
Why?
Metabolic Clearance Rate
1
2004
69
0.230
Why?
Plasminogen Activator Inhibitor 1
1
2004
6
0.230
Why?
Equipment Design
4
2020
286
0.230
Why?
Recurrence
8
2016
658
0.230
Why?
History, 21st Century
2
2019
56
0.230
Why?
Pericardiocentesis
1
2024
15
0.230
Why?
Angiography
7
2012
127
0.230
Why?
Femoral Artery
4
2019
102
0.230
Why?
Monocytes
1
2004
131
0.230
Why?
History, 20th Century
2
2019
95
0.230
Why?
Secondary Prevention
2
2015
78
0.230
Why?
Artifacts
1
2004
53
0.230
Why?
Reoperation
5
2013
453
0.230
Why?
Reproducibility of Results
6
2016
1183
0.220
Why?
Staphylococcal Infections
1
2007
269
0.220
Why?
Cardiomyopathy, Hypertrophic
1
2004
29
0.220
Why?
Angina Pectoris
4
2020
20
0.220
Why?
Disease Models, Animal
10
2011
1411
0.220
Why?
Nitric Oxide Synthase Type II
4
2008
64
0.220
Why?
Aged, 80 and over
10
2017
3137
0.210
Why?
Catheterization
4
2019
100
0.210
Why?
Materials Testing
2
2020
56
0.210
Why?
American Heart Association
4
2015
32
0.210
Why?
Hospital Mortality
5
2019
409
0.210
Why?
Anti-Arrhythmia Agents
4
2004
81
0.200
Why?
Body Composition
1
2004
320
0.200
Why?
Cyclosporins
5
1989
9
0.200
Why?
Vasodilation
2
2021
97
0.200
Why?
Constriction, Pathologic
3
2017
95
0.200
Why?
Exercise Tolerance
5
1997
40
0.200
Why?
Odds Ratio
4
2016
548
0.200
Why?
Propanolamines
3
2011
14
0.190
Why?
Retreatment
2
2012
56
0.190
Why?
Epoprostenol
5
2001
25
0.180
Why?
Heart Valve Prosthesis Implantation
2
2016
80
0.180
Why?
Diet, Sodium-Restricted
1
2000
5
0.180
Why?
Up-Regulation
4
2011
446
0.180
Why?
Enalapril
3
1989
15
0.180
Why?
Hospitalization
5
2011
663
0.180
Why?
Cardiomyopathies
9
2003
114
0.180
Why?
Administration, Oral
9
2015
430
0.180
Why?
United States Department of Veterans Affairs
1
2022
286
0.180
Why?
Ischemia
1
2021
153
0.180
Why?
Logistic Models
5
2018
896
0.180
Why?
Angioplasty
1
2020
20
0.170
Why?
Calcitonin Gene-Related Peptide
2
2009
23
0.170
Why?
6-Ketoprostaglandin F1 alpha
3
2008
6
0.170
Why?
Plaque, Atherosclerotic
1
2019
39
0.170
Why?
Life Style
1
2000
140
0.170
Why?
Heart Rate
7
1993
299
0.160
Why?
Specialization
1
2019
46
0.160
Why?
Atherectomy
1
2019
13
0.160
Why?
Quality Improvement
2
2011
205
0.160
Why?
Atrial Natriuretic Factor
4
1996
25
0.160
Why?
Cost-Benefit Analysis
2
2014
269
0.160
Why?
Russia
4
2019
10
0.160
Why?
Radial Artery
1
2019
29
0.160
Why?
Prevalence
5
2018
955
0.160
Why?
Peripheral Arterial Disease
1
2019
67
0.160
Why?
Proto-Oncogene Proteins c-akt
3
2009
155
0.160
Why?
Multivariate Analysis
7
2016
579
0.160
Why?
Catheterization, Peripheral
1
2019
46
0.160
Why?
Feasibility Studies
2
2020
382
0.150
Why?
Patient Care Planning
1
2019
67
0.150
Why?
Tachycardia, Ventricular
2
2004
43
0.150
Why?
Pulmonary Wedge Pressure
8
2001
27
0.150
Why?
Patient Care
1
1998
57
0.150
Why?
Emergency Medical Services
1
2019
110
0.150
Why?
Diabetes Mellitus, Type 2
1
2004
484
0.150
Why?
Patient Safety
1
2018
102
0.150
Why?
Medicare
2
2011
245
0.150
Why?
Blood Pressure
12
1997
520
0.150
Why?
Fistula
2
1996
26
0.150
Why?
Intra-Aortic Balloon Pumping
2
1994
7
0.150
Why?
Education, Medical
1
2019
112
0.150
Why?
Waiting Lists
3
2007
55
0.140
Why?
Antihypertensive Agents
4
2001
124
0.140
Why?
Cardiac Pacing, Artificial
3
2008
28
0.140
Why?
Adventitia
1
2017
4
0.140
Why?
Education, Medical, Graduate
3
2013
211
0.140
Why?
Curriculum
3
2013
397
0.140
Why?
Quality of Life
5
2008
836
0.140
Why?
Renin
5
1996
19
0.140
Why?
Enoximone
9
1990
10
0.140
Why?
Advisory Committees
2
2014
61
0.140
Why?
Myocardial Revascularization
3
2012
14
0.140
Why?
Norepinephrine
6
1996
113
0.140
Why?
Substance Withdrawal Syndrome
2
1997
167
0.140
Why?
Phosphorylation
6
2008
526
0.130
Why?
Nitric Oxide Synthase
2
2008
73
0.130
Why?
Propensity Score
1
2017
125
0.130
Why?
Hypertension, Pulmonary
7
1997
121
0.130
Why?
Treatment Failure
4
2018
116
0.130
Why?
Simvastatin
2
2008
29
0.130
Why?
Hypertension
6
2011
532
0.130
Why?
Health Personnel
3
2007
250
0.130
Why?
Benzazepines
2
2006
19
0.130
Why?
Renal Insufficiency, Chronic
1
2018
170
0.130
Why?
Phosphodiesterase Inhibitors
4
2007
25
0.130
Why?
Graft Rejection
9
2009
168
0.120
Why?
Muscle Contraction
1
1996
111
0.120
Why?
Disease Progression
6
2008
820
0.120
Why?
Postpericardiotomy Syndrome
1
2015
4
0.120
Why?
Diagnostic Techniques, Cardiovascular
2
2012
4
0.120
Why?
Magnetic Resonance Imaging
1
2022
1525
0.120
Why?
Age Factors
5
2021
1090
0.120
Why?
Angioscopy
1
1994
3
0.120
Why?
Cardiomyopathy, Dilated
3
1996
39
0.120
Why?
Colchicine
1
2015
24
0.120
Why?
Smad3 Protein
1
2014
9
0.120
Why?
Systole
4
2010
71
0.120
Why?
Cholesterol, Dietary
1
2014
19
0.120
Why?
Th2 Cells
1
2014
22
0.120
Why?
Tunica Intima
1
1994
55
0.120
Why?
Cyclic AMP-Dependent Protein Kinases
3
2011
53
0.120
Why?
Patient Care Management
1
2014
18
0.120
Why?
Venous Thrombosis
1
2015
88
0.120
Why?
Area Under Curve
3
2022
178
0.120
Why?
Myocardial Contraction
4
2009
110
0.120
Why?
Receptors, LDL
1
2014
67
0.120
Why?
Acute Disease
5
2019
367
0.120
Why?
Health Care Costs
1
1995
168
0.120
Why?
Cardiovascular System
1
2014
50
0.110
Why?
Cohort Studies
6
2022
1406
0.110
Why?
Punctures
3
2019
48
0.110
Why?
Diuretics
4
1998
28
0.110
Why?
Atherosclerosis
2
2014
210
0.110
Why?
Thromboembolism
1
2014
54
0.110
Why?
Survival Rate
6
2018
905
0.110
Why?
Dependovirus
1
2014
103
0.110
Why?
Cardiac Output
10
1997
46
0.110
Why?
Transfection
1
2014
354
0.110
Why?
Remote Consultation
1
2014
29
0.110
Why?
Drug Costs
1
2014
39
0.110
Why?
Quality Indicators, Health Care
2
2011
86
0.110
Why?
Arrhythmias, Cardiac
2
2012
90
0.110
Why?
Infusions, Intravenous
8
2011
211
0.110
Why?
Case-Control Studies
3
2013
1129
0.110
Why?
Septal Occluder Device
1
2013
30
0.110
Why?
Echocardiography, Doppler, Color
1
2013
22
0.110
Why?
Pulmonary Edema
1
2013
20
0.110
Why?
Echocardiography, Doppler
2
2016
52
0.110
Why?
Hypertrophy, Left Ventricular
3
2009
40
0.110
Why?
Signal Transduction
3
2009
1608
0.100
Why?
General Surgery
1
2014
106
0.100
Why?
Evidence-Based Medicine
2
2011
247
0.100
Why?
Heparin
2
2024
91
0.100
Why?
Cause of Death
7
2007
147
0.100
Why?
Pleural Effusion
1
2013
38
0.100
Why?
Kidney Diseases
2
2007
211
0.100
Why?
Ultrasonography
3
2010
429
0.100
Why?
Echocardiography
7
2005
381
0.100
Why?
Image Processing, Computer-Assisted
1
2014
243
0.100
Why?
Sex Factors
5
2022
691
0.100
Why?
Embolism, Cholesterol
1
2011
2
0.100
Why?
Carbazoles
2
2005
16
0.100
Why?
Creatine Kinase
2
2003
30
0.100
Why?
Exercise
1
1996
493
0.100
Why?
Cardiovascular Surgical Procedures
2
2012
10
0.100
Why?
Kidney
4
2005
672
0.100
Why?
Equipment Failure
3
2008
63
0.100
Why?
Random Allocation
4
2005
286
0.100
Why?
Milrinone
1
2011
9
0.100
Why?
Isoenzymes
2
2003
168
0.090
Why?
Death
2
2022
21
0.090
Why?
Insurance Claim Review
1
2011
36
0.090
Why?
Diabetes Complications
3
2011
118
0.090
Why?
Enkephalin, D-Penicillamine (2,5)-
2
2009
3
0.090
Why?
Unnecessary Procedures
1
2011
20
0.090
Why?
Prednisone
3
1989
100
0.090
Why?
Amrinone
2
1987
2
0.090
Why?
Oxygen Consumption
5
1996
188
0.090
Why?
Cells, Cultured
5
2009
1587
0.090
Why?
Body Weight
3
2007
512
0.090
Why?
Preoperative Care
2
2007
167
0.090
Why?
Thrombectomy
1
2011
69
0.090
Why?
Cyclooxygenase 2 Inhibitors
2
2007
17
0.090
Why?
Injections, Intra-Arterial
2
2015
13
0.090
Why?
Necrosis
1
2010
175
0.090
Why?
Texas
4
2006
142
0.090
Why?
Surgical Instruments
1
2010
27
0.090
Why?
Disease Management
3
2014
175
0.090
Why?
Magnetic Resonance Imaging, Cine
1
2010
59
0.090
Why?
Endothelium, Vascular
3
2007
251
0.090
Why?
Diatrizoate
1
1989
3
0.080
Why?
Reperfusion Injury
2
2007
87
0.080
Why?
Iopamidol
1
1989
2
0.080
Why?
Receptors, Calcitonin Gene-Related Peptide
1
2009
4
0.080
Why?
Ethanolamines
2
1986
13
0.080
Why?
ROC Curve
2
2022
225
0.080
Why?
Hyperlipidemias
2
2011
51
0.080
Why?
Drug Administration Routes
1
2008
10
0.080
Why?
Leukotriene B4
1
2008
1
0.080
Why?
Arachidonate 5-Lipoxygenase
1
2008
2
0.080
Why?
Fatal Outcome
2
2007
194
0.080
Why?
Hemostasis, Surgical
1
2008
11
0.080
Why?
Phospholipases A
2
2006
14
0.080
Why?
Phospholipases A2
2
2006
15
0.080
Why?
Patient Transfer
1
2009
94
0.080
Why?
Comorbidity
1
2010
610
0.080
Why?
Meta-Analysis as Topic
1
2008
38
0.080
Why?
Analysis of Variance
2
2008
553
0.080
Why?
Drainage
1
2008
79
0.080
Why?
Heart Diseases
3
2006
211
0.070
Why?
Sulfonamides
2
2008
125
0.070
Why?
Myocardial Reperfusion
1
2007
8
0.070
Why?
Mitogen-Activated Protein Kinase 3
1
2007
48
0.070
Why?
Tetrazoles
1
2007
40
0.070
Why?
Combined Modality Therapy
1
2009
638
0.070
Why?
Dipyridamole
1
2007
9
0.070
Why?
Prosthesis Failure
2
2012
108
0.070
Why?
Microinjections
2
2018
33
0.070
Why?
Prostaglandin D2
1
2007
21
0.070
Why?
Cyclooxygenase 1
1
2007
5
0.070
Why?
Drug Interactions
2
2007
207
0.070
Why?
Patient Admission
1
2007
73
0.070
Why?
Nitroso Compounds
1
2006
4
0.070
Why?
Calcium Signaling
1
2007
56
0.070
Why?
Thoracic Surgery
1
2007
19
0.070
Why?
Mass Screening
2
2004
346
0.070
Why?
Enzyme Induction
1
2006
79
0.070
Why?
Anemia, Macrocytic
1
1986
2
0.070
Why?
Deferoxamine
1
1986
9
0.070
Why?
Anemia, Megaloblastic
1
1986
3
0.070
Why?
PPAR gamma
1
2007
72
0.070
Why?
Biotin
1
2006
46
0.070
Why?
Ubiquinone
1
2006
12
0.070
Why?
NF-kappa B
1
2008
315
0.070
Why?
Hemofiltration
1
2006
7
0.070
Why?
Magnesium
1
2006
36
0.070
Why?
Multicenter Studies as Topic
4
2005
88
0.070
Why?
Electric Countershock
1
2006
30
0.070
Why?
Forecasting
1
2007
145
0.070
Why?
Heart Atria
1
2006
58
0.070
Why?
Intracranial Embolism
1
2006
27
0.070
Why?
Patient Education as Topic
2
2000
314
0.070
Why?
Diagnosis, Differential
2
2012
1034
0.070
Why?
Radiology
1
2008
130
0.070
Why?
Ischemic Preconditioning
1
2005
4
0.070
Why?
Aortic Rupture
1
2006
18
0.070
Why?
Triiodobenzoic Acids
1
2005
9
0.060
Why?
Partnership Practice
1
2005
1
0.060
Why?
Myocardial Stunning
1
2005
1
0.060
Why?
Organizational Affiliation
1
2005
2
0.060
Why?
Health Planning
1
2005
13
0.060
Why?
Foreign Bodies
1
2006
63
0.060
Why?
Metoprolol
1
2005
13
0.060
Why?
Gastrointestinal Hemorrhage
1
2006
79
0.060
Why?
Pyrrolidines
1
2006
67
0.060
Why?
Device Removal
1
2006
84
0.060
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2006
122
0.060
Why?
Iron
1
1986
122
0.060
Why?
Aortic Coarctation
1
2006
33
0.060
Why?
Sensitivity and Specificity
3
2006
858
0.060
Why?
Water-Electrolyte Balance
1
1985
20
0.060
Why?
Accidents, Traffic
1
2006
87
0.060
Why?
Isoxazoles
1
2005
14
0.060
Why?
Prostaglandin-Endoperoxide Synthases
1
2005
24
0.060
Why?
Education, Medical, Continuing
1
2005
68
0.060
Why?
Intramolecular Oxidoreductases
1
2005
14
0.060
Why?
Tetralogy of Fallot
1
2006
81
0.060
Why?
Ephedrine
1
2004
21
0.060
Why?
Regional Blood Flow
1
2004
106
0.060
Why?
Hyperhomocysteinemia
1
2004
29
0.060
Why?
Leadership
1
2005
100
0.060
Why?
Body Surface Area
1
2004
26
0.060
Why?
Membrane Proteins
1
2007
347
0.060
Why?
Polyethylene Terephthalates
1
2004
10
0.060
Why?
Brachiocephalic Trunk
1
2004
6
0.060
Why?
Ventricular Remodeling
1
2004
53
0.060
Why?
Antioxidants
1
2006
234
0.060
Why?
Pregnancy Complications, Cardiovascular
1
2004
29
0.060
Why?
Vascular Endothelial Growth Factor A
1
2005
183
0.060
Why?
Injections, Intravenous
4
2004
135
0.060
Why?
Abnormalities, Multiple
1
2006
167
0.060
Why?
Arteriosclerosis
1
2004
54
0.060
Why?
Swine Diseases
1
2004
7
0.060
Why?
Myocarditis
1
1984
45
0.060
Why?
Inflammation
2
2007
603
0.060
Why?
Enoxaparin
1
2024
27
0.060
Why?
ATP-Binding Cassette Transporters
1
2004
34
0.060
Why?
Potassium Channels
1
2004
33
0.060
Why?
Edema
1
2004
68
0.060
Why?
Cytochrome P-450 Enzyme System
1
2005
194
0.060
Why?
Vasoconstrictor Agents
1
2004
83
0.060
Why?
Glomerular Filtration Rate
2
2018
110
0.060
Why?
Radiography
3
2006
485
0.060
Why?
Immunohistochemistry
2
2005
972
0.050
Why?
Sample Size
1
2003
37
0.050
Why?
Staphylococcus aureus
1
2007
327
0.050
Why?
Heart Aneurysm
1
1983
13
0.050
Why?
Health Policy
2
2012
151
0.050
Why?
Retroperitoneal Space
1
2002
32
0.050
Why?
C-Reactive Protein
1
2003
143
0.050
Why?
Methoxamine
2
1993
4
0.050
Why?
Internship and Residency
1
2008
442
0.050
Why?
Mitral Valve Prolapse
1
1982
3
0.050
Why?
Drug Synergism
3
2007
152
0.050
Why?
Renal Dialysis
1
2003
170
0.050
Why?
Morphine Derivatives
1
2022
28
0.050
Why?
Anesthesia
1
2002
73
0.050
Why?
Pain Clinics
1
2001
3
0.050
Why?
Hospital Units
1
2001
10
0.050
Why?
Clinical Trials, Phase II as Topic
1
2001
46
0.050
Why?
Hospitals
1
2022
172
0.050
Why?
Dogs
3
1993
185
0.050
Why?
Benchmarking
2
2011
61
0.050
Why?
Nitroglycerin
3
2004
9
0.050
Why?
Comprehensive Health Care
1
2000
9
0.040
Why?
Fluoroscopy
2
1993
45
0.040
Why?
Heart Arrest
1
2002
150
0.040
Why?
Autopsy
1
2000
47
0.040
Why?
Cardiology Service, Hospital
1
2000
15
0.040
Why?
Tissue Scaffolds
1
2020
36
0.040
Why?
Vitamins
1
2000
63
0.040
Why?
Arkansas
2
2016
1987
0.040
Why?
Amyloidosis
2
1991
77
0.040
Why?
Biocompatible Materials
1
2020
68
0.040
Why?
Public Policy
2
2012
38
0.040
Why?
Oxidative Stress
1
2004
759
0.040
Why?
Anti-Inflammatory Agents
2
2015
160
0.040
Why?
Diastole
2
1993
70
0.040
Why?
Peripheral Vascular Diseases
1
2000
22
0.040
Why?
Renal Artery Obstruction
1
2000
22
0.040
Why?
Lymphocytes
2
1991
154
0.040
Why?
Disease-Free Survival
1
2000
450
0.040
Why?
Hospitals, Public
1
1999
7
0.040
Why?
Placebos
2
1990
84
0.040
Why?
Carotid Stenosis
1
2000
64
0.040
Why?
Syndrome
3
2006
237
0.040
Why?
Morbidity
1
1999
128
0.040
Why?
Risk Adjustment
1
2019
16
0.040
Why?
Mice, Knockout
2
2014
835
0.040
Why?
Adolescent
7
1996
6402
0.040
Why?
Injections, Intralesional
1
2018
31
0.040
Why?
Quality of Health Care
1
2000
184
0.040
Why?
Internationality
1
2018
41
0.040
Why?
Patient Care Team
1
2000
258
0.040
Why?
Radiation Dosage
1
2019
158
0.040
Why?
Losartan
1
1998
27
0.040
Why?
Drug Evaluation
2
1995
28
0.040
Why?
Ventricular Pressure
1
1997
16
0.040
Why?
Administration, Intravenous
1
2018
70
0.040
Why?
Health Services Needs and Demand
1
1999
154
0.040
Why?
Immunoblotting
2
2008
116
0.040
Why?
Sex Characteristics
1
1999
191
0.040
Why?
Respiration
2
1996
99
0.040
Why?
Internal Mammary-Coronary Artery Anastomosis
1
1997
5
0.040
Why?
Radiation Monitoring
1
2017
7
0.040
Why?
International Cooperation
2
2007
44
0.040
Why?
Biopsy
5
1994
591
0.040
Why?
Calcium Channel Blockers
1
1997
63
0.040
Why?
Cardiomegaly
2
1988
39
0.040
Why?
Enzyme-Linked Immunosorbent Assay
2
2008
234
0.040
Why?
Patient Compliance
1
1998
230
0.030
Why?
Ventricular Function, Right
1
1997
39
0.030
Why?
Hormones
2
1987
57
0.030
Why?
Isotonic Contraction
1
1996
1
0.030
Why?
Interferon-alpha
1
1996
48
0.030
Why?
Isometric Contraction
1
1996
21
0.030
Why?
Vascular Resistance
3
1997
55
0.030
Why?
Forearm
1
1996
33
0.030
Why?
Mice
3
2014
5657
0.030
Why?
Socioeconomic Factors
1
1998
583
0.030
Why?
Italy
1
2015
26
0.030
Why?
Data Collection
3
2011
282
0.030
Why?
Carbon Dioxide
1
1996
94
0.030
Why?
Blood Flow Velocity
1
2015
100
0.030
Why?
Delivery of Health Care
1
1998
308
0.030
Why?
Phlebography
1
2015
60
0.030
Why?
Neurotransmitter Agents
1
1995
35
0.030
Why?
Cost Savings
1
1995
58
0.030
Why?
Radionuclide Angiography
1
1994
2
0.030
Why?
Tubulin Modulators
1
2015
27
0.030
Why?
Atherectomy, Coronary
1
1994
6
0.030
Why?
Cross-Sectional Studies
1
2020
1573
0.030
Why?
Monte Carlo Method
1
1995
86
0.030
Why?
Decision Support Techniques
1
1995
71
0.030
Why?
Time
1
2014
26
0.030
Why?
Journal Impact Factor
1
2014
7
0.030
Why?
Liver Transplantation
1
1996
151
0.030
Why?
Kinetics
2
1986
632
0.030
Why?
Models, Cardiovascular
2
2004
21
0.030
Why?
Genetic Vectors
1
2014
128
0.030
Why?
Nervous System Diseases
1
1995
88
0.030
Why?
Fibrosis
1
2014
178
0.030
Why?
Pulmonary Circulation
1
1993
34
0.030
Why?
Monitoring, Physiologic
1
2014
127
0.030
Why?
Learning Curve
1
2013
18
0.030
Why?
Drug Monitoring
1
1993
78
0.030
Why?
Ischemic Attack, Transient
1
2013
56
0.030
Why?
Ultrasonics
1
1993
31
0.030
Why?
Jugular Veins
1
1993
31
0.030
Why?
Apoptosis
2
2011
1092
0.030
Why?
Cardiac Imaging Techniques
1
2012
8
0.030
Why?
Alprostadil
1
1992
10
0.030
Why?
Gene Expression Regulation
2
2008
964
0.030
Why?
Mice, Inbred C57BL
2
2008
1777
0.030
Why?
Half-Life
2
1998
85
0.020
Why?
Tissue Survival
1
2012
10
0.020
Why?
Obesity
1
2000
1097
0.020
Why?
Myocardial Perfusion Imaging
1
2012
16
0.020
Why?
Smoking
2
2011
506
0.020
Why?
Endocardium
2
1989
7
0.020
Why?
Tomography, Emission-Computed, Single-Photon
1
2012
49
0.020
Why?
Phosphodiesterase 3 Inhibitors
1
2011
1
0.020
Why?
Adrenergic beta-1 Receptor Antagonists
1
2011
6
0.020
Why?
Adrenergic beta-Agonists
1
1991
41
0.020
Why?
Health Status
1
1993
299
0.020
Why?
In Situ Nick-End Labeling
1
2011
52
0.020
Why?
Goals
1
1991
41
0.020
Why?
Recovery of Function
1
2012
187
0.020
Why?
Diagnostic Imaging
1
2012
179
0.020
Why?
Mannitol
1
1990
15
0.020
Why?
Body Water
1
1990
24
0.020
Why?
Critical Care
1
2012
214
0.020
Why?
Dopamine
1
1991
170
0.020
Why?
Vasoconstriction
1
1990
55
0.020
Why?
Graft Survival
1
1991
153
0.020
Why?
Sodium
1
1990
92
0.020
Why?
Blood Volume
1
1990
69
0.020
Why?
Program Development
1
2011
162
0.020
Why?
Adrenergic beta-2 Receptor Antagonists
1
2009
1
0.020
Why?
Adrenergic beta-2 Receptor Agonists
1
2009
2
0.020
Why?
Transplantation, Homologous
1
2009
140
0.020
Why?
Liver
1
1994
1105
0.020
Why?
Isoquinolines
1
2008
28
0.020
Why?
Cell Death
1
2009
174
0.020
Why?
Serine
1
2008
37
0.020
Why?
Tyrphostins
1
2008
8
0.020
Why?
Janus Kinases
1
2008
8
0.020
Why?
Physical Exertion
1
1988
44
0.020
Why?
Selection Bias
1
2008
15
0.020
Why?
Electrophoretic Mobility Shift Assay
1
2008
73
0.020
Why?
Pulse
1
1988
14
0.020
Why?
Pennsylvania
3
1993
30
0.020
Why?
Ischemic Preconditioning, Myocardial
1
2007
2
0.020
Why?
Bayes Theorem
1
1988
105
0.020
Why?
Organ Culture Techniques
1
2007
48
0.020
Why?
Enzyme Activation
1
2008
272
0.020
Why?
Creatine Kinase, BB Form
1
2007
1
0.020
Why?
Receptors, Purinergic P1
1
2007
8
0.020
Why?
Survival
1
2007
12
0.020
Why?
Immunologic Factors
1
2008
112
0.020
Why?
Theophylline
1
2007
21
0.020
Why?
Pyridazines
1
1987
11
0.020
Why?
5'-Nucleotidase
1
2007
12
0.020
Why?
Nitriles
1
2007
52
0.020
Why?
Renin-Angiotensin System
1
1987
59
0.020
Why?
Bundle-Branch Block
1
1987
11
0.020
Why?
Blood Coagulation
1
2007
58
0.020
Why?
Butadienes
1
2007
47
0.020
Why?
Models, Chemical
1
2007
64
0.020
Why?
Premedication
1
2007
16
0.020
Why?
Pain
2
1982
372
0.020
Why?
Evaluation Studies as Topic
3
1992
108
0.020
Why?
Drug Combinations
1
2007
126
0.020
Why?
Depression, Chemical
1
1986
14
0.020
Why?
Coenzymes
1
2006
3
0.020
Why?
Stimulation, Chemical
1
1986
29
0.020
Why?
Vasoactive Intestinal Peptide
1
1986
19
0.020
Why?
Heart Function Tests
1
1986
11
0.020
Why?
Fluid Therapy
1
2007
75
0.020
Why?
Protein Kinase Inhibitors
1
2008
205
0.020
Why?
Oncogene Protein v-akt
1
2006
10
0.020
Why?
Alanine
1
2006
41
0.020
Why?
Phosphoric Monoester Hydrolases
1
2006
21
0.020
Why?
Receptors, Vasopressin
1
2006
23
0.020
Why?
Amidines
1
2006
8
0.020
Why?
Lactates
1
1986
30
0.020
Why?
Educational Measurement
1
2008
204
0.020
Why?
Benzylamines
1
2006
15
0.020
Why?
Sulfones
1
2006
24
0.020
Why?
PTEN Phosphohydrolase
1
2006
53
0.020
Why?
Long-Term Care
1
1986
50
0.020
Why?
Research Design
1
2008
344
0.020
Why?
Models, Animal
1
2006
227
0.020
Why?
Magnetic Resonance Angiography
1
2006
71
0.020
Why?
Heart Conduction System
1
2005
23
0.020
Why?
Nitric Oxide
1
2007
253
0.020
Why?
Diabetes Mellitus
1
1989
280
0.020
Why?
Osmotic Pressure
1
1985
11
0.020
Why?
Osmolar Concentration
1
1985
63
0.020
Why?
Safety
1
2005
77
0.020
Why?
Enzyme Inhibitors
1
2007
378
0.020
Why?
Aortography
1
2004
35
0.010
Why?
Glyburide
1
2004
6
0.010
Why?
Scleroderma, Systemic
1
1984
6
0.010
Why?
Anastomosis, Surgical
1
2004
66
0.010
Why?
Ventricular Fibrillation
1
2004
16
0.010
Why?
Anesthesia, Obstetrical
1
2004
39
0.010
Why?
Verapamil
1
1984
22
0.010
Why?
Models, Biological
1
2007
719
0.010
Why?
Vascular Surgical Procedures
1
2006
164
0.010
Why?
Statistics as Topic
1
2004
88
0.010
Why?
Patient Discharge
1
2006
318
0.010
Why?
Transcription Factors
1
2007
565
0.010
Why?
NG-Nitroarginine Methyl Ester
1
2003
18
0.010
Why?
Cesarean Section
1
2004
159
0.010
Why?
Pulmonary Artery
1
1984
145
0.010
Why?
Swine
1
2004
396
0.010
Why?
Endpoint Determination
1
2002
24
0.010
Why?
Thorax
1
1982
16
0.010
Why?
Anxiety Disorders
1
1982
125
0.010
Why?
Popliteal Artery
1
2000
27
0.010
Why?
Iliac Artery
1
2000
34
0.010
Why?
Hospitals, University
1
1999
77
0.010
Why?
Mortality
1
1999
97
0.010
Why?
Brain
1
2006
1310
0.010
Why?
Cross-Over Studies
1
1998
223
0.010
Why?
Dyspnea
1
1977
74
0.010
Why?
Abdomen
1
1977
75
0.010
Why?
Pregnancy
1
2004
2466
0.010
Why?
Physical Examination
1
1977
93
0.010
Why?
Fatigue
1
1977
118
0.010
Why?
Physical Fitness
1
1997
54
0.010
Why?
Walking
1
1997
97
0.010
Why?
Actuarial Analysis
1
1996
10
0.010
Why?
Hepatitis C
1
1996
80
0.010
Why?
Nitroprusside
1
1992
11
0.010
Why?
Neck
1
1993
99
0.010
Why?
Pilot Projects
1
1995
702
0.010
Why?
HLA Antigens
1
1992
53
0.010
Why?
Transplantation, Heterotopic
1
1991
7
0.010
Why?
Immunity, Cellular
1
1991
69
0.010
Why?
Regression Analysis
1
1991
385
0.010
Why?
Cyclosporine
1
1991
65
0.010
Why?
Cytotoxicity, Immunologic
1
1990
56
0.010
Why?
Histocompatibility Testing
1
1990
12
0.010
Why?
Transplantation, Heterologous
1
1989
75
0.010
Why?
Cell Division
1
1990
294
0.010
Why?
Length of Stay
1
1991
624
0.000
Why?
Phenotype
1
1990
728
0.000
Why?
Bundle of His
1
1987
8
0.000
Why?
Atrial Flutter
1
1987
9
0.000
Why?
Cobalt
1
1986
16
0.000
Why?
Histological Techniques
1
1986
9
0.000
Why?
Endomyocardial Fibrosis
1
1985
3
0.000
Why?
Doxorubicin
1
1986
233
0.000
Why?
Thallium
1
1984
6
0.000
Why?
Radioisotopes
1
1984
17
0.000
Why?
Heart Defects, Congenital
1
1990
584
0.000
Why?
Microcirculation
1
1984
71
0.000
Why?
Radionuclide Imaging
1
1984
116
0.000
Why?
Infant
1
1990
3564
0.000
Why?
Child, Preschool
1
1990
3863
0.000
Why?
Child
1
1990
6826
0.000
Why?
Uretsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description